z-logo
open-access-imgOpen Access
Chronic Helminth Infection Does Not Exacerbate Mycobacterium tuberculosis Infection
Author(s) -
Marc P. Hübner,
Kristin E. Killoran,
Michael Rajnik,
Samuel Wilson,
Kevin C. Yim,
Mari. Torrero,
C. Paul Morris,
B. V. Nikonenko,
Jorge C. G. Blanco,
Val G. Hemming,
Edward Mitre
Publication year - 2012
Publication title -
plos neglected tropical diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.99
H-Index - 135
eISSN - 1935-2735
pISSN - 1935-2727
DOI - 10.1371/journal.pntd.0001970
Subject(s) - immunology , mycobacterium tuberculosis , immune system , biology , tuberculosis , chronic infection , interferon gamma , spleen , immunity , helminthiasis , helminths , helminth infections , cotton rat , medicine , pathology , virus
Background Chronic helminth infections induce a Th2 immune shift and establish an immunoregulatory milieu. As both of these responses can suppress Th1 immunity, which is necessary for control of Mycobacterium tuberculosis (MTB) infection, we hypothesized that chronic helminth infections may exacerbate the course of MTB. Methodology/Principal Findings Co-infection studies were conducted in cotton rats as they are the natural host for the filarial nematode Litomosoides sigmodontis and are an excellent model for human MTB. Immunogical responses, histological studies, and quantitative mycobacterial cultures were assessed two months after MTB challenge in cotton rats with and without chronic L. sigmodontis infection. Spleen cell proliferation and interferon gamma production in response to purified protein derivative were similar between co-infected and MTB-only infected animals. In contrast to our hypothesis, MTB loads and occurrence and size of lung granulomas were not increased in co-infected animals. Conclusions/Significance These findings suggest that chronic filaria infections do not exacerbate MTB infection in the cotton rat model. While these results suggest that filaria eradication programs may not facilitate MTB control, they indicate that it may be possible to develop worm-derived therapies for autoimmune diseases that do not substantially increase the risk for infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom